82
48
Growth Score
-6 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
463476
Avineuro Pharmaceuticals discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry.
- Alexandre V. Ivachtchenko: CEO & CSO
About the Company
Avineuro Pharmaceuticals, Inc. discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry.
Founded in August 2008 and headquartered in San Diego, California Avineuro is managed by professionals experienced in drug discovery and development. By acquiring lead compounds through collaborations and partnerships,
Avineuro develops novel products and extends the reach of marketed compounds for indications with a significant commercial potential.
Avineuro emphasizes a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.
